Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium

Research output: Contribution to journal › Article › Academic › peer-review

7 Citations (Scopus)

62 Downloads (Pure)

Research programs

@article{3b154fb190c048a984dde7f0d659a899,

title = "Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium",

author = "Katia Verhamme and C Lucet and A Meerhaeghe and Guy Brusselle and M Lambert",

year = "2019",

doi = "10.1183/23120541.00253-2018",

language = "Undefined/Unknown",

volume = "5",

journal = "ERJ Open Research",

issn = "2312-0541",

publisher = "European Respiratory Society",

number = "4",

}

TY - JOUR

T1 - Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium

AU - Verhamme, Katia

AU - Lucet, C

AU - Meerhaeghe, A

AU - Brusselle, Guy

AU - Lambert, M

PY - 2019

Y1 - 2019

U2 - 10.1183/23120541.00253-2018

DO - 10.1183/23120541.00253-2018

M3 - Article

C2 - 31777749

SN - 2312-0541

VL - 5

JO - ERJ Open Research

JF - ERJ Open Research

IS - 4

M1 - 00253-2018

ER -